This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
|Articles|November 17, 2011
Regulatory Roundup: ICH Steering Committee Approves Revised Guideline for Genotoxicity Testing and Data Interpretation for Medicines
Author(s)Pharmaceutical Technology Editors
ICH Steering Committee Approves Revised Guideline for Genotoxicity Testing and Data Interpretation for Medicines.
Advertisement
The International Conference on Harmonization (ICH) steering committee and working groups met in Seville, Spain, earlier this month. The groups meet twice annually to discuss, revise, and approve various harmonization guidelines. At the latest meeting, the steering committee approved a revised ICH S2(R1) guideline for genotoxicity testing and data interpretation for medicines intended for human use. The Quality Implementation Working Group (IWG) completed three points-to-consider documents on process validation/process verification, the role of modeling in QbD, and design space. All documents will soon appear on the
The US Pharmacopeia has developed a memorandum of understanding with the Chilean Pharmacopeia Foundation to help provide the quality and safety of medicines in Chile and the United States. USP has recently established similar partnerships with Russia and the Ukraine.
Advertisement
Related to this article
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Advertisement
Advertisement